Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
migraine research foundation
3
×
national blog main
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
detroit blog main
detroit top stories
eptinezumab
erenumab
fremanezumab
galcanezumab
lasmiditan
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
triptans
wisconsin blog main
What
approval
drug
fda
migraine
new
won
3
×
class
decades
acute
addresses
amgen
arguments
big
candidates
causes
commercialized
companies
competitors
condition
developed
drugs
eli
friday
gets
giant
giving
head
lasmiditan
lilly
lilly’s
make
medication
medicines
meeting
neuro
nod
oks
oral
pain
pharmaceutical
Language
unset
Current search:
" migraine research foundation "
×
won
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines